Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration to Healthy Adult Subjects Under Fasting Condition

NCT05186129 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Clopid® 75 mg Tablet
DRUG: Plavix® 75mg Tablet

Sponsor

Center for Bioequivalence Studies and Clinical Research

Collaborators

[object Object]